Qlife Holding AB (publ) (QLIFE.ST)
SEK 2.1
(5.53%)
SEK 2.1
(5.53%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -159.95 Million SEK | -71.74% |
| 2022 | -93.14 Million SEK | -140.07% |
| 2021 | -38.79 Million SEK | -92.06% |
| 2020 | -20.2 Million SEK | -283.2% |
| 2019 | -5.27 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -12.97 Million SEK | -55.42% |
| 2024 Q1 | -8.35 Million SEK | 92.51% |
| 2023 FY | -159.95 Million SEK | -71.74% |
| 2023 Q3 | -8.92 Million SEK | 60.68% |
| 2023 Q4 | -111.54 Million SEK | -1149.69% |
| 2023 Q1 | -16.78 Million SEK | 33.97% |
| 2023 Q2 | -22.7 Million SEK | -35.3% |
| 2022 Q3 | -20.67 Million SEK | -2.62% |
| 2022 Q2 | -20.15 Million SEK | -31.98% |
| 2022 Q1 | -15.26 Million SEK | 3.4% |
| 2022 FY | -93.14 Million SEK | -140.07% |
| 2022 Q4 | -25.41 Million SEK | -22.9% |
| 2021 Q1 | -6.7 Million SEK | 11.77% |
| 2021 FY | -38.79 Million SEK | -92.06% |
| 2021 Q4 | -15.8 Million SEK | -5.38% |
| 2021 Q3 | -14.99 Million SEK | -32.41% |
| 2021 Q2 | -11.32 Million SEK | -68.88% |
| 2020 FY | -20.2 Million SEK | -283.2% |
| 2020 Q4 | -7.6 Million SEK | -175.73% |
| 2020 Q3 | -2.75 Million SEK | -142.27% |
| 2020 Q2 | -1.13 Million SEK | 86.93% |
| 2020 Q1 | -8.7 Million SEK | 63.75% |
| 2019 Q3 | -3.09 Million SEK | -17.77% |
| 2019 FY | -5.27 Million SEK | 0.0% |
| 2019 Q1 | -1.89 Million SEK | 0.0% |
| 2019 Q2 | -2.62 Million SEK | -38.83% |
| 2019 Q4 | -24.01 Million SEK | -675.8% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.83 Million SEK | -105.496% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 254.547% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 254.547% |
| Arcoma AB | 2.56 Million SEK | 6338.534% |
| Bactiguard Holding AB (publ) | -138.38 Million SEK | -15.59% |
| BICO Group AB (publ) | -835.7 Million SEK | 80.86% |
| Boule Diagnostics AB (publ) | 24.97 Million SEK | 740.413% |
| CellaVision AB (publ) | 130.3 Million SEK | 222.751% |
| Clinical Laserthermia Systems AB (publ) | -79.79 Million SEK | -100.466% |
| Chordate Medical Holding AB (publ) | -29.18 Million SEK | -448.045% |
| C-Rad AB (publ) | 35.52 Million SEK | 550.213% |
| Duearity AB (publ) | -26.19 Million SEK | -510.752% |
| Dignitana AB (publ) | -17.36 Million SEK | -821.246% |
| Episurf Medical AB (publ) | -94.8 Million SEK | -68.73% |
| Getinge AB (publ) | 2.41 Billion SEK | 106.632% |
| Scandinavian Real Heart AB (Publ) | -67.97 Million SEK | -135.308% |
| Iconovo AB (publ) | -45.89 Million SEK | -248.535% |
| Integrum AB (publ) | 4.03 Million SEK | 4066.692% |
| Luxbright AB (publ) | -25.37 Million SEK | -530.365% |
| Mentice AB (publ) | -2.81 Million SEK | -5578.239% |
| OssDsign AB (publ) | -130.49 Million SEK | -22.578% |
| Paxman AB (publ) | 8.33 Million SEK | 2020.24% |
| Promimic AB (publ) | -9.22 Million SEK | -1634.504% |
| SciBase Holding AB (publ) | -55.58 Million SEK | -187.768% |
| ScandiDos AB (publ) | -14.64 Million SEK | -992.073% |
| Sectra AB (publ) | 428.38 Million SEK | 137.339% |
| Sedana Medical AB (publ) | -59.61 Million SEK | -168.329% |
| Senzime AB (publ) | -134.14 Million SEK | -19.238% |
| SpectraCure AB (publ) | -20.44 Million SEK | -682.525% |
| Stille AB | 26.64 Million SEK | 700.3% |
| Vitrolife AB (publ) | -3.85 Billion SEK | 95.846% |
| Xvivo Perfusion AB (publ) | 91.82 Million SEK | 274.206% |